Obermatt

Ansell

ASX:ANN · AU000000ANN9
Health Care Equipment & SuppliesLarge

360

80
EV / EBIT75
Price / Owner Earnings26
Owner Earnings Yield55
Dividend Yield89
Price/Sales64
EV / Gross Profit68
Price/Book66
Return on Capital67
Cash Return on Capital54
Return on Equity57
EBIT Margin72
Gross Profitability46
Cash Conversion54
Accruals54
Owner Earnings Margin52
Sales growth22
Profit Growth86
Long-Term EPS Growth51
Owner Earnings Growth81
Reinvestment61
Price momentum32
Debt load31
Refinancing56
Debt Payback39
Liquidity45
Analyst ratings16
Opinion Changes50
Price Target Upside57
Market mood67
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ansell clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeASX
Founded1920
Employees3,310
Websiteansell.com
ISINAU000000ANN9
Last UpdateApr 2, 2026
Themes
Environment, Health and Safety (EH&S)

Description

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions. Business Segments The company operates through several strategic business segments, each tailored to meet the specific needs of its…

Analysis

Middle-of-the-road

Ansell Limited is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 23.9× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 9% yearly growth; analysts expect 10%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 12/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
68
2023202420252026

All-time high

69

Mar 2026

All-time low

21

Jan 2024

Average rank

45

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
64
55
67
64
Price/Earnings
57
59
67
75
Price/Book
66
47
64
52
Dividend Yield
89
63
64
70
Value (overall)
80
70
61
75

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ansell with its peers
PolyNovo
ASX:PNV
33
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Riverstone Holdings
SES:AP4
31
CountrySingapore
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Apex Biotechnology
TAI:1733
72
CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Menicon
TYO:7780
51
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Mani
TYO:7730
77
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Pro Medicus
ASX:PME
67
CountryAustralia
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →